ConCallIQ
Go Pro
GALAXYSURF Diversified 06 Nov 2025

Galaxy Surfactants Limited — Q2 FY26

Galaxy Surfactants reported a challenging Q2 FY26 with consolidated volumes flat YoY and QoQ, as multiple headwinds converged.

bearish high
Compare with...
Revenue ₹1,326 Cr
EBITDA
PAT ₹66 Cr
EBITDA Margin
Duration 50 min
Read Time 1 min read

✓ Verified against BSE filing

2-Minute Summary

✦ AI-Generated from Full Transcript

Galaxy Surfactants reported a challenging Q2 FY26 with consolidated volumes flat YoY and QoQ, as multiple headwinds converged. US reciprocal tariffs (50% on Indian exports) disrupted specialty care demand and delayed project pipelines, with a full-year EBITDA impact of 3-5% of FY25 EBITDA. Elevated fatty alcohol prices triggered reformulation in India, costing an estimated 3,000-4,000 tons of volume in the quarter. GST rate rationalization caused inventory destocking by FMCG clients, further pressuring domestic volumes. Management expects Q3 to remain similar to Q2, with recovery likely only from Q4 FY26, contingent on tariff resolution, fatty alcohol price correction, and GST normalization. The company is mitigating via market share gains with non-Tier 1 customers, shifting US-bound production to Egypt, and launching new sunscreen ingredients. Volumes flat, EBITDA per metric ton at ₹17,300, reformulation impact of 3,000-4,000 tons, and tariff EBITDA impact of 3-5% are key figures. Risk: prolonged reformulation or tariff persistence could structurally erode market position.

Risks4 trackedTranscriptfull text
Research workspace

Focused Modules

!Risks 4 risks

Risk Intelligence

Prolonged reformulation impact

View Risks →
Transcript Full text

Call Transcript

Full transcript text is available on this route.

Read Transcript →

Quarter Snapshot

Consolidated Volumes Flat YoY
0% YoY

Consolidated volumes remained flat year-on-year and quarter-on-quarter.

EBITDA per Metric Ton ₹17,300
-5% YoY

EBITDA per metric ton for H1 FY26 was approximately ₹17,300, down from ₹18,700 in H1 FY25.

India Volume Loss from Reformulation 3,000-4,000 tons
N/A

Reformulation due to high fatty alcohol prices led to a volume loss of 3,000-4,000 tons in India in Q2.

Specialty Care Volume Growth (Non-US) Double-digit
+10%+ YoY

Specialty care products delivered double-digit volume growth driven by non-US geographies.

Fast read

Guidance and risk preview

Top guidance Q3 FY26 volumes expected similar to Q2

Management expects Q3 volumes to remain at similar levels as Q2, with recovery only from Q4 FY26.

Top risk Prolonged reformulation impact

High fatty alcohol prices may persist, leading to continued reformulation by customers and volume loss beyond Q2.

View Risks →